Loading…
Loading…
Healthcare
Revenue 24.8% · Earnings 30.8%
P/B 9.72
Rel. volume 9.7x · Delivery 26.6%
AJANTPHARM is not 20% or more below its highest close since 09 Jun 2025, and there's no earlier fall that large on record.
Sign in to generate a summary. Summaries already generated for a company are visible to everyone.
RSI 57.4 · Drawdown -5.6%
D/E 5.9% · Gross margin 77.2%
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2026-03-31 | ₹5,453 Cr | ₹1,056 Cr |
| 2025-03-31 | ₹4,648 Cr | ₹920 Cr |
| 2024-03-31 | ₹4,209 Cr | ₹816 Cr |
| 2023-03-31 | ₹3,743 Cr | ₹588 Cr |